Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK gets conditional marketing nod in EU for pazopanib to treat RCC
GSK gets conditional marketing nod in EU for pazopanib to treat RCC
GSK gets conditional marketing nod in EU for pazopanib to treat RCC
Submitted by
admin
on June 17, 2010 - 9:50am
Source:
Pharmabiz
News Tags:
GSK
Votrient
renal cell carcinoma
Headline:
GSK gets conditional marketing nod in EU for pazopanib to treat RCC
Do Not Allow Advertisers to Use My Personal information
